Table 3 Patient responses
Pre-Treatment PET/CT (SUV) | Â |
 Patients | 86 (91%) |
 Median SUV | 8.4 |
 Range (SUV) | 1.5–31.9 |
Post-Treatment PET/CT (SUV) | Â |
 Patients | 71 (75%) |
 Median SUV | 3.2 |
 Range (SUV) | 1.0–25.5 |
Time to Post-Treatment PET/CT | Â |
 Median (months) | 3.1 |
 Range (months) | 1.6–26.3 |
PERCIST/RECIST Response | Â |
 Patients | 84 (88%) |
 CMR/CR | 69 (82%) |
 PMR/PR | 14 (17%) |
 SMD/SD | 1 (1%) |
 PMD/PD | N/A |
Recurrence | Â |
 Patients w/ Recurrence | 21 (22%) |
 Lobar Failure | 8 (8%) |
 Regional Failure | 3 (3%) |
 Locoregional Failure | 4 (4%) |
 Distant Failure | 6 (6%) |
Overall Survival | Â |
 Median (months) | 15.3 |
 Range (months) | 0.85–70.7 |